- Home
- BOSC vs CVKD Comparison
BOSC vs CVKD Comparison
Compare BOSC & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOSC
- CVKD
- Stock Information
- Founded
- BOSC 1990
- CVKD 2022
- Country
- BOSC Israel
- CVKD United States
- Employees
- BOSC N/A
- CVKD N/A
- Industry
- BOSC Computer Communications Equipment
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- BOSC Telecommunications
- CVKD Health Care
- Exchange
- BOSC Nasdaq
- CVKD Nasdaq
- Market Cap
- BOSC 28.4M
- CVKD 29.5M
- IPO Year
- BOSC 1996
- CVKD 2023
- Fundamental
- Price
- BOSC $4.82
- CVKD $10.28
- Analyst Decision
- BOSC
- CVKD Strong Buy
- Analyst Count
- BOSC 0
- CVKD 1
- Target Price
- BOSC N/A
- CVKD $32.00
- AVG Volume (30 Days)
- BOSC 492.7K
- CVKD 23.0K
- Earning Date
- BOSC 08-21-2025
- CVKD 08-06-2025
- Dividend Yield
- BOSC N/A
- CVKD N/A
- EPS Growth
- BOSC 35.10
- CVKD N/A
- EPS
- BOSC 0.49
- CVKD N/A
- Revenue
- BOSC $43,688,000.00
- CVKD N/A
- Revenue This Year
- BOSC N/A
- CVKD N/A
- Revenue Next Year
- BOSC N/A
- CVKD N/A
- P/E Ratio
- BOSC $10.32
- CVKD N/A
- Revenue Growth
- BOSC 0.84
- CVKD N/A
- 52 Week Low
- BOSC $2.50
- CVKD $5.70
- 52 Week High
- BOSC $5.50
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- BOSC 58.21
- CVKD 24.53
- Support Level
- BOSC $4.63
- CVKD $10.00
- Resistance Level
- BOSC $5.11
- CVKD $13.30
- Average True Range (ATR)
- BOSC 0.26
- CVKD 0.89
- MACD
- BOSC 0.00
- CVKD -0.39
- Stochastic Oscillator
- BOSC 59.46
- CVKD 4.67
About BOSC B.O.S. Better Online Solutions
BOS Better Online Solutions Ltd is a provider of Intelligent Robotics and Supply Chain solutions for enterprises. The company manages its business in three reportable divisions: the Intelligent Robotics segment, the RFID Division segment, and the Supply Chain Solutions segment. The majority of revenue derives from Supply Chain Solutions which distributes electro-mechanical components, mainly to customers in the aerospace, defense, and other industries, and is a supply chain service provider for aviation customers that seek a comprehensive solution to their components-supply needs. Geographically company derives the majority of its revenue from Israel.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.